These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9197463)

  • 21. Human erythrocyte hexokinase deficiency. Characterization of a mutant enzyme with abnormal regulatory properties.
    Rijksen G; Staal GE
    J Clin Invest; 1978 Aug; 62(2):294-301. PubMed ID: 27532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothesis: structures, evolution, and ancestor of glucose kinases in the hexokinase family.
    Kawai S; Mukai T; Mori S; Mikami B; Murata K
    J Biosci Bioeng; 2005 Apr; 99(4):320-30. PubMed ID: 16233797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional consequences of mutation of highly conserved serine residues, found at equivalent positions in the N- and C-terminal domains of mammalian hexokinases.
    Baijal M; Wilson JE
    Arch Biochem Biophys; 1992 Oct; 298(1):271-8. PubMed ID: 1524437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic and regulatory properties of HK I(+), a modified form of the type I isozyme of mammalian hexokinase in which interactions between the N- and C-terminal halves have been disrupted.
    Hashimoto M; Wilson JE
    Arch Biochem Biophys; 2002 Mar; 399(1):109-15. PubMed ID: 11883910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular model of human beta-cell glucokinase built by analogy to the crystal structure of yeast hexokinase B.
    St Charles R; Harrison RW; Bell GI; Pilkis SJ; Weber IT
    Diabetes; 1994 Jun; 43(6):784-91. PubMed ID: 8194664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downeast anemia (dea), a new mouse model of severe nonspherocytic hemolytic anemia caused by hexokinase (HK(1)) deficiency.
    Peters LL; Lane PW; Andersen SG; Gwynn B; Barker JE; Beutler E
    Blood Cells Mol Dis; 2001; 27(5):850-60. PubMed ID: 11783948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, expression, purification, and properties of a putative plasma membrane hexokinase from Solanum chacoense.
    Claeyssen E; Wally O; Matton DP; Morse D; Rivoal J
    Protein Expr Purif; 2006 May; 47(1):329-39. PubMed ID: 16376570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP-binding site of human brain hexokinase as studied by molecular modeling and site-directed mutagenesis.
    Zeng C; Aleshin AE; Hardie JB; Harrison RW; Fromm HJ
    Biochemistry; 1996 Oct; 35(40):13157-64. PubMed ID: 8855953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.
    Morris MT; DeBruin C; Yang Z; Chambers JW; Smith KS; Morris JC
    Eukaryot Cell; 2006 Dec; 5(12):2014-23. PubMed ID: 17028241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.
    Ukonmaanaho EM; Dell'Anna S; Hakonen A; Wartiovaara-Kautto U; Kakko S; Rab MAE; van Oirschot B; Kraatari-Tiri M; van Wijk R; Rahikkala E
    Br J Haematol; 2024 May; 204(5):2040-2048. PubMed ID: 38415930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships.
    Gidh-Jain M; Takeda J; Xu LZ; Lange AJ; Vionnet N; Stoffel M; Froguel P; Velho G; Sun F; Cohen D
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1932-6. PubMed ID: 8446612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis.
    de Vooght KM; van Solinge WW; van Wesel AC; Kersting S; van Wijk R
    Haematologica; 2009 Sep; 94(9):1203-10. PubMed ID: 19608687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The crystal structure of Trypanosoma cruzi glucokinase reveals features determining oligomerization and anomer specificity of hexose-phosphorylating enzymes.
    Cordeiro AT; Cáceres AJ; Vertommen D; Concepción JL; Michels PA; Versées W
    J Mol Biol; 2007 Oct; 372(5):1215-26. PubMed ID: 17761195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-step purification of a fully active hexahistidine-tagged human hexokinase type I overexpressed in Escherichia coli.
    Palma F; Longhi S; Agostini D; Stocchi V
    Protein Expr Purif; 2001 Jun; 22(1):38-44. PubMed ID: 11388797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rare genetically determined electrophoretic variant of human leucocyte type III hexokinase.
    Katzen HM; Soderman DD
    Arch Biochem Biophys; 1988 May; 262(2):626-35. PubMed ID: 3364986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression and biological significance of hexokinase in erythroid cells.
    Murakami K; Kanno H; Tancabelic J; Fujii H
    Acta Haematol; 2002; 108(4):204-9. PubMed ID: 12432216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type II isozyme possess catalytic sites.
    Tsai HJ; Wilson JE
    Arch Biochem Biophys; 1996 May; 329(1):17-23. PubMed ID: 8619630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional consequences of naturally occurring variants of human hexokinase II.
    Malkki M; Laakso M; Deeb SS
    Diabetologia; 1998 Oct; 41(10):1205-9. PubMed ID: 9794109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic properties of the N- and C-terminal halves of human hexokinase II.
    Ahn KJ; Kim J; Yun M; Park JH; Lee JD
    BMB Rep; 2009 Jun; 42(6):350-5. PubMed ID: 19558793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonaggregating mutant of recombinant human hexokinase I exhibits wild-type kinetics and rod-like conformations in solution.
    Aleshin AE; Malfois M; Liu X; Kim CS; Fromm HJ; Honzatko RB; Koch MH; Svergun DI
    Biochemistry; 1999 Jun; 38(26):8359-66. PubMed ID: 10387081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.